127.96
-0.25 (-0.19%)
Penutupan Terdahulu | 128.21 |
Buka | 128.18 |
Jumlah Dagangan | 4,731,774 |
Purata Dagangan (3B) | 2,531,034 |
Modal Pasaran | 8,274,674,176 |
Harga / Jualan (P/S) | 14.49 |
Harga / Buku (P/B) | 24.19 |
Julat 52 Minggu | |
Tarikh Pendapatan | 30 Jul 2025 - 4 Aug 2025 |
Margin Keuntungan | -27.70% |
Margin Operasi (TTM) | -27.50% |
EPS Cair (TTM) | -2.51 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 55.50% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | -99.40% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 208.50% |
Nisbah Semasa (MRQ) | 2.80 |
Aliran Tunai Operasi (OCF TTM) | -145.55 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -20.78 M |
Pulangan Atas Aset (ROA TTM) | -9.75% |
Pulangan Atas Ekuiti (ROE TTM) | -47.71% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Biotechnology (US) | Menurun | Menurun |
Biotechnology (Global) | Menurun | Menurun | |
Stok | Blueprint Medicines Corporation | Bercampur | Menaik |
AISkor Stockmoo
Konsensus Penganalisis | 1.0 |
Aktiviti Orang Dalam | 3.0 |
Volatiliti Harga | -3.0 |
Purata Bergerak Teknikal | -2.5 |
Osilator Teknikal | 4.0 |
Purata | 0.50 |
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer. |
|
Sektor | Healthcare |
Industri | Biotechnology |
Gaya Pelaburan | Small Growth |
% Dimiliki oleh Orang Dalam | 0.91% |
% Dimiliki oleh Institusi | 109.39% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Rock Springs Capital Management Lp | 31 Mar 2025 | 1,007,569 |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 135.00 (Scotiabank, 5.50%) | Pegang |
135.00 (Stephens & Co., 5.50%) | Pegang | |
135.00 (HC Wainwright & Co., 5.50%) | Beli | |
Median | 129.00 (0.81%) | |
Rendah | 129.00 (Wells Fargo, 0.81%) | Pegang |
129.00 (UBS, 0.81%) | Pegang | |
129.00 (Morgan Stanley, 0.81%) | Pegang | |
129.00 (Citigroup, 0.81%) | Pegang | |
129.00 (JP Morgan, 0.81%) | Pegang | |
129.00 (Wedbush, 0.81%) | Pegang | |
Purata | 130.90 (2.30%) | |
Jumlah | 1 Beli, 9 Pegang | |
Harga Purata @ Panggilan | 125.55 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Wells Fargo | 17 Jun 2025 | 129.00 (0.81%) | Pegang | 128.23 |
Morgan Stanley | 05 Jun 2025 | 129.00 (0.81%) | Pegang | 127.90 |
UBS | 05 Jun 2025 | 129.00 (0.81%) | Pegang | 127.90 |
Citigroup | 04 Jun 2025 | 129.00 (0.81%) | Pegang | 128.10 |
Stephens & Co. | 03 Jun 2025 | 135.00 (5.50%) | Pegang | 127.60 |
JP Morgan | 02 Jun 2025 | 129.00 (0.81%) | Pegang | 127.79 |
Needham | 02 Jun 2025 | 130.00 (1.59%) | Pegang | 127.79 |
28 Apr 2025 | 130.00 (1.59%) | Beli | 88.51 | |
Scotiabank | 02 Jun 2025 | 135.00 (5.50%) | Pegang | 127.79 |
Wedbush | 02 Jun 2025 | 129.00 (0.81%) | Pegang | 127.79 |
16 Apr 2025 | 128.00 (0.03%) | Beli | 82.11 | |
HC Wainwright & Co. | 02 May 2025 | 135.00 (5.50%) | Beli | 104.64 |
Papar semua |
Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
---|---|---|---|---|
ALBERS JEFFREY W. | 128.12 | - | 3,902 | 499,924 |
BECKMAN DANIELLA | 128.12 | - | 3,902 | 499,924 |
BORISY ALEXIS | 128.12 | - | 3,902 | 499,924 |
COATS LONNEL | 128.12 | - | 3,902 | 499,924 |
DABLE HABIB J | 128.12 | - | 3,902 | 499,924 |
GOLDBERG MARK ALAN | 128.12 | - | 3,902 | 499,924 |
SEELY LYNN | 128.12 | - | 3,902 | 499,924 |
TSAI JOHN | 128.12 | - | 3,902 | 499,924 |
Jumlah Keseluruhan Kuantiti Bersih | 31,216 | |||
Jumlah Keseluruhan Nilai Bersih ($) | 3,999,394 | |||
Purata Pembelian Keseluruhan ($) | 128.12 | |||
Purata Jualan Keseluruhan ($) | - |
Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
---|---|---|---|---|---|---|
TSAI JOHN | Pengarah | 18 Jun 2025 | Diperolehi (+) | 3,902 | 128.12 | 499,924 |
COATS LONNEL | Pengarah | 18 Jun 2025 | Diperolehi (+) | 3,902 | 128.12 | 499,924 |
DABLE HABIB J | Pengarah | 18 Jun 2025 | Diperolehi (+) | 3,902 | 128.12 | 499,924 |
BORISY ALEXIS | Pengarah | 18 Jun 2025 | Diperolehi (+) | 3,902 | 128.12 | 499,924 |
BECKMAN DANIELLA | Pengarah | 18 Jun 2025 | Diperolehi (+) | 3,902 | 128.12 | 499,924 |
SEELY LYNN | Pengarah | 18 Jun 2025 | Diperolehi (+) | 3,902 | 128.12 | 499,924 |
GOLDBERG MARK ALAN | Pengarah | 18 Jun 2025 | Diperolehi (+) | 3,902 | 128.12 | 499,924 |
ALBERS JEFFREY W. | Pengarah | 18 Jun 2025 | Diperolehi (+) | 3,902 | 128.12 | 499,924 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |